Pathological uptake with 18-Fluorocholine versus 99mTc-MIBI in the location of the parathyroid glands in hyperparathyroidism. Systematic review and meta-analysis
Pathological uptake with 18-Fluorocholine versus 99mTc-MIBI in the location of the parathyroid glands in hyperparathyroidism. Systematic review and meta-analysis
Summary IntroductionThe location of the pathological parathyroid glands in hyperparathyroidism is usually carried out by means of 99mTc-sestamibi scintigraphy, which increases its precision by adding the ultrasound examination. The non-localization of the parathyroid glands increases the difficulties for surgical removal. To increase the detection of pathological glands, other radioactive tracers are used, such as methionine, fluorocholine or 18F-flurpiridaz. ObjectiveTo establish if PET / CT with 18-Fluorocholine in patients with hyperparathyroidism increases the number of uptakes compared to the 99mTc-sestamibi scan. MethodSystematic review and meta-analysis. Two subgroups were analyzed. Subgroup 1: trials comparing both techniques as an initial exploration. Thirteen studies including 1131 examinations were selected (596 PET / CT with 18-Fluorocholine vs. 535 scintigraphy with 99mTc-sestamibi). Meta-analysis was performed following the random effects model and the odds ratio was calculated. Subgroup 2: studies that include 18-Fluorocholine as a rescue examination in patients with a previous negative study with a 99mTc-sestamibi scan. 17 articles including 412 examinations with 359 patients in which there was at least one uptake were selected. Meta-analysis of the prevalence of the number of patients in whom there was at least one uptake was performed using the random effects model. ResultsSubgroup 1: The number of patients in which at least one uptake occurs is significantly higher with the 18-Fluorocholine examinations (OR 4.264, 95% CI 2.400-7.577). The prevalence of uptake with 18-Fluorocholine is 0.91 [0.86, 0.95] and with sestamibi 0.68 [0.56, 0.80]. Subgroup 2: the prevalence of uptake among patients with previous negative MIBI studies was 0.90 [0.87, 0.94]. The probability of detection of both techniques in this group reaches 0.98. Publication bias in the meta-analyzes is low. Discussion18-Fluorocholine protocols provide higher precision, clearer images, with faster acquisition as well as being readily available for most PET / CT centers. ConclusionThe PET / CT study with 18-Fluorocholine can be recommended as a study for the location of pathological parathyroid glands after studies with negative MIBI.
Alonso Pilar Tamayo、G¨?mez Esther Mart¨an、Refoyo Jos¨| Luis Pardal、Cend¨?n Sof¨aa Ferreira
Nuclear Medicine, University Hospital of Salamanca, Salamanca Biomedical Research Institute (IBSAL)Nuclear Medicine, University Hospital of Salamanca, Salamanca Biomedical Research Institute (IBSAL)Otolaryngology and Head and Neck Surgery, University Hospital of Salamanca, Salamanca Biomedical Research Institute (IBSAL)Otolaryngology and Head and Neck Surgery, University Hospital of Salamanca, Salamanca Biomedical Research Institute (IBSAL)
医学研究方法临床医学内科学
Hyperparathyroidismparathyroidsestamibi scintigraphycholine PETfluorocholine
Alonso Pilar Tamayo,G¨?mez Esther Mart¨an,Refoyo Jos¨| Luis Pardal,Cend¨?n Sof¨aa Ferreira.Pathological uptake with 18-Fluorocholine versus 99mTc-MIBI in the location of the parathyroid glands in hyperparathyroidism. Systematic review and meta-analysis[EB/OL].(2025-03-28)[2025-04-26].https://www.medrxiv.org/content/10.1101/2020.07.25.20161927.点此复制
评论